Nizoral

What Nizoral does

Nizoral is an over-the-counter (OTC) anti-dandruff shampoo brand owned and operated by Kramer Laboratories, Inc., a privately held US consumer health company headquartered in Somerset County, New Jersey. The brand is built around a single proprietary active, Ketoconazole 1%, a clinically proven antifungal that targets the scalp fungus underlying dandruff rather than only the visible symptoms; Nizoral is positioned as the only OTC anti-dandruff shampoo containing Ketoconazole. Its core SKU, Nizoral® Anti-Dandruff Shampoo, is dosed twice weekly and is clinically supported to control flaking, scaling, and itching, and is also marketed as safe for color-treated, chemically processed, and gray hair — a differentiator versus harsher medicated shampoos.

The product line has been extended with Nizoral® Psoriasis Shampoo & Conditioner (a separate sub-brand at nizoralpsoriasis.com), targeting the adjacent scalp psoriasis indication with the same Ketoconazole-based franchise. Nizoral is sold as a one-time-purchase OTC consumer good across a broad US retail footprint — drug stores (CVS, Walgreens), mass merchandisers (Walmart), grocery chains (Wegmans, Meijer, Publix), and leading e-commerce platforms (Amazon, Walmart.com) — with end customers being individual consumers: general dandruff sufferers (up to 50% of the global population), people with color-treated or chemically processed hair, and consumers concerned about hair loss associated with dandruff.

Kramer Laboratories operates a multi-brand consumer health portfolio that includes Nizoral, Nizoral Psoriasis, Funginail, Safetussin, Hongocura, Kaopectate, and ArcadiaCH, with operational support provided by The Emerson Group. The business model is straightforward OTC consumer product sales; no subscription, auto-replenishment, or direct-to-consumer subscription model is disclosed in the source material. Distribution is described as omnichannel and US-led, though the brand is identified as a key global player in the $6.8B (2024) anti-dandruff shampoo market alongside Head & Shoulders, Dove, Selsun Blue, and Neutrogena.

Name

Nizoral

Legal name

Kramer Laboratories, Inc.

Website

https://nizoral.com

Company type

Private

Operating status

Operating

Short description

Nizoral is an over-the-counter anti-dandruff shampoo brand owned by Kramer Laboratories, Inc., offering the only US OTC shampoo with Ketoconazole 1% antifungal, sold through drug stores, mass merchandisers, and e-commerce platforms to consumers with dandruff and related scalp conditions.

Ownership category

akta.pro rank

Product category

Anti-dandruff shampoo

NAICS

Soap and Cleaning Compound Manufacturing (32561)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Treatments & Scalp Care (Serums, Oils, Anti-dandruff, Growth) (CRABABAE)

akta.pro secondary industry

Shampoo & Scalp Cleansers (CRABABAA)

Keywords

• Anti-dandruff shampoo
• Ketoconazole shampoo
• Scalp care products
• OTC medicated shampoo
• Consumer scalp treatment

Headquarters

HQ city

Fort Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Marketing or Sales, Supply Chain, Personnel, Operations

Revenue model

1. Consumer Product Sales: Nizoral generates revenue through direct sales of its anti-dandruff shampoo products via retail stores and e-commerce platforms. The product is sold as an over-the-counter (OTC) consumer health item.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels3 records

Core offering

Nizoral is a consumer health brand that sells over-the-counter anti-dandruff shampoo formulated with Ketoconazole 1%, a clinically proven antifungal ingredient that controls the scalp fungus causing dandruff. The shampoo is used twice a week to control flaking, scaling, and itching from dandruff, and is marketed as the only OTC anti-dandruff shampoo containing Ketoconazole. The brand also offers a separate Nizoral Psoriasis Shampoo & Conditioner line for scalp psoriasis.

Product overview

Nizoral is a consumer health brand offering over-the-counter anti-dandruff shampoos. The core product is Nizoral® Anti-Dandruff Shampoo containing Ketoconazole 1%, which is the only OTC dandruff shampoo with this clinically proven antifungal ingredient. The company also offers Nizoral® Psoriasis Shampoo & Conditioner for scalp psoriasis. Both products are distributed through major retail channels including drug stores, grocery stores, and mass merchandisers.

Differentiator

Problem solved

Functional benefit

Brands

• Nizoral® Psoriasis Shampoo & Conditioner: Product for scalp psoriasis treatment, available at nizoralpsoriasis.com

Products and services

• Nizoral Anti-Dandruff Shampoo - Ketoconazole 1% Over-the-counter anti-dandruff shampoo containing Ketoconazole 1%, a clinically proven antifungal active ingredient that controls the scalp fungus causing dandruff. Used twice weekly to control flaking, scaling, and itching, and safe for color-treated, chemically processed, and gray hair. Sold to individual consumers via major retail and e-commerce channels.
• Nizoral Psoriasis Shampoo & Conditioner Shampoo and conditioner product line designed for scalp psoriasis symptoms, sold as a separate product line from the core anti-dandruff shampoo under the Nizoral brand. Targeted at consumers with scalp psoriasis seeking an over-the-counter scalp care option.

Quantifiable outcome

• 10X more effective at fighting fungus (the primary cause of dandruff) than the active ingredient in the leading dandruff shampoo, based on laboratory testing of active ingredients
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators6 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Selsun Blue (Sanofi / Chattem): Sanofi/Chattem's medicated anti-dandruff shampoo brand using selenium sulfide; named alongside Nizoral as a key player in the global anti-dandruff market holding combined ~61% share with other leaders.
• Dove Hair Derma Care (Unilever): Unilever's Dove anti-dandruff shampoo line; cited as a top-5 player in the global anti-dandruff shampoo market alongside Nizoral, with comparable mass retail distribution.
• Neutrogena T/Gel (Johnson & Johnson): J&J's dermatologist-positioned anti-dandruff shampoo with coal tar; identified in the source data as a top-5 anti-dandruff player globally and a direct competitor on drugstore shelves and Amazon.
• Head & Shoulders (Procter & Gamble): Procter & Gamble's flagship anti-dandruff shampoo brand and Nizoral's primary direct competitor; holds the #1 global share and co-leads with Nizoral on Amazon's anti-dandruff category per the source data.

Broad incumbents

• Pantene (Procter & Gamble): P&G's mass-market haircare franchise with anti-dandruff SKUs; competes for the same shelf space and shopper occasion but is positioned broadly across haircare rather than specializing in dandruff treatment.
• Herbal Essences (Procter & Gamble): P&G's broad haircare brand with shampoo lines that compete for the same grocery/drug store shelf space as Nizoral but lack a medicated anti-dandruff specialization.

Emerging players

• Maple Holistics Tea Tree Shampoo: DTC-leaning natural shampoo brand that positions tea-tree oil as a dandruff/scalp-care solution; overlaps with Nizoral on the dandruff use case but competes on clean/natural positioning.
• Paul Mitchell Tea Tree Special Shampoo: Salon-channel tea tree shampoo frequently cited as a natural alternative for flaky scalp; partial overlap with Nizoral on scalp care but distributed primarily through professional salon channels.
• Denorex (McGregor/Health Enterprises): Smaller medicated anti-dandruff shampoo brand competing in the drugstore channel alongside Nizoral with similar clinical positioning but limited distribution scale.

Others

• Kramer Laboratories (parent portfolio context): Parent company of Nizoral; included for context because it operates adjacent OTC consumer health brands (Funginail, Safetussin, Kaopectate, ArcadiaCh) sharing the same retail channels and operational infrastructure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nizoral